AB-3PRGD2, CAS 2416165-76-7

Product Description: AB-3PRGD2 is a radiotherapeutic agent targeting integrin αvβ3. AB-3PRGD2 shows improved tumor uptake and prolonged tumor retention, leading to significantly enhanced tumor growth suppression. AB-3PRGD2 can remodel the tumor immune microenvironment by upregulating PD-L1 expression and increasing tumor-infiltrating CD8+ T cells[1].

Formula: C137H215IN30O45S

References: [1]Shi J, et al. Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockade. Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):955-969.

CAS Number: 2416165-76-7

Molecular Weight: 3161.32

Research Area: Cancer

Target: Integrin;PD-1/PD-L1

• SKU: MEXHY-171331-0
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-171331-0
• Package Unit: Get quote
• Quantity Unit: STK